High potency of lipid conjugated TLR7 agonist requires nanoparticulate or liposomal formulation
Gadd, Adam J.R., Castelletto, Valeria, Kabova, Elena, Shankland, Kenneth, Perrie, Yvonne, Hamley, Ian, Cobb, Alexander J.A., Greco, F., Edwards, Alexander D.Volume:
123
Language:
english
Journal:
European Journal of Pharmaceutical Sciences
DOI:
10.1016/j.ejps.2018.07.048
Date:
October, 2018
File:
PDF, 653 KB
english, 2018